Prof. Laurence Albiges is Head of the Medical Oncology Department at Gustave Roussy Cancer Campus (appointed October 2021) and Professor of Medical Oncology at the University of Paris-Saclay, France. Her clinical and research focus centres on metastatic renal cell carcinoma (RCC) and rare forms of non-clear cell renal carcinoma. She has contributed to the development of targeted agents and immune checkpoint inhibitors for RCC and has published over 350 peer-reviewed articles, being listed among the Highly Cited Researchers by Clarivate since 2023. She has served on the EAU RCC guidelines panel (2016–2024), the ESMO RCC guidelines panel, and coordinated the ESMO Genitourinary (non-prostate) Faculty (2020–2024). Since May 2023, she is the PI of the Horizon Europe-funded CARE1 project — an eight-year multicentre European trial across eight countries focused on optimising first-line treatment strategies for metastatic kidney cancer. She is a member of the GETUG steering committee and has received the Conquer Cancer Foundation Merit Award (ASCO GU 2015).